Artelo raises ~$9.5M private placement to buy Solana; gets UK MHRA nod for Phase 1 trial

ARTELO BIOSCIENCES, INC.

Gross proceeds ~$9.475M from 593,252 shares at $10.20 plus prefunded warrants; also issues Market Priced ($10.20) and $50.00 warrants.
Net proceeds from shares will be used to purchase SOL; warrant proceeds for working capital and additional SOL.
UK MHRA provided favorable guidance for first-in-human Phase 1 trial of ART12.11 (CBD:TMP cocrystal) for anxiety/depression.
Offering expected to close Aug 5, 2025; registration statement to be filed within 15 days of closing.

item 1.01item 3.02item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.